Investor Presentaiton slide image

Investor Presentaiton

US Business at a glance 5th Largest Pharma Company in the US Generics Market Dermatology Segment Comprehensive Portfolio Robust Pipeline • Largest generic dermatology company and 3rd largest branded dermatology company in the US • Wide basket of 599 ANDAS filed & 445 approved ANDAs across multiple therapies • 154 ANDAs pending FDA approval, including a combination of complex generics, FTF opportunities and pure generics Market Presence • Presence in generics, branded & OTC segments Flexible Manufacturing Dosage Forms • Integrated manufacturer with flexibility for manufacturing onshore/offshore • Liquids, Creams, Ointments, Gels, Sprays, Injectable, Tablets, Capsules, Drug-Device combination © Sun Pharmaceutical Industries Limited. All Rights Reserved. SUN PHARMA * Source: Evaluate Pharma for 12 months ended Dec 2014 17
View entire presentation